Acute myeloid leukemia: Clinical Practice Guidelines in Oncology Journal Article

  


Authors: O'Donnell, M. R.; Appelbaum, F. R.; Baer, M. R.; Byrd, J. C.; Coutre, S. E.; Damon, L. E.; Erba, H. P.; Estey, E.; Foran, J.; Lancet, J.; Maness, L. J.; Maslak, P. G.; Millenson, M.; Moore, J. O.; Przepiorka, D.; Shami, P.; Smith, B. D.; Stone, R. M.; Tallman, M. S.
Article Title: Acute myeloid leukemia: Clinical Practice Guidelines in Oncology
Abstract: Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades. © Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; treatment outcome; leukemia; antibiotic agent; acute granulocytic leukemia; fludarabine; clinical feature; clinical trial; histopathology; review; salvage therapy; cancer risk; cytarabine; methotrexate; neurotoxicity; breast cancer; etoposide; incidence; cytogenetics; nccn clinical practice guidelines; antifungal agent; dexamethasone; steroid; patient assessment; patient monitoring; practice guideline; hematopoietic stem cell transplantation; childhood cancer; hodgkin disease; sarcoma; arsenic trioxide; patient care; cancer regression; mitoxantrone; lymphoma; daunorubicin; promyelocytic leukemia; blood transfusion; ionizing radiation; cancer epidemiology; idarubicin; diagnostic test; anthracycline; immunosuppressive treatment; testis cancer; chromosome analysis; granulocyte colony stimulating factor; retinoic acid; sodium chloride; diuretic agent; gemtuzumab ozogamicin; mercaptopurine; occupational exposure; leukapheresis; rasburicase; acute myeloid leukemia; chemotherapeutic agents; myelodysplasia; anthraquinone; leukemia treatment; benzene; eye drops
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 4
Issue: 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2006-01-01
Start Page: 16
End Page: 36
Language: English
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-33645053537&partnerID=40&md5=e808a873c8b5dc72080cca64fbd8bec2
Notes: --- - "Cited By (since 1996): 5" - "Export Date: 4 June 2012" - "Source: Scopus"